Home / Research / Publications / Actionable Targets in Pancreatic Cancer Detected by Imunohistochemistry (IHC), Microarray (MA) Fluorescent in situ Hybridization (FISH) and Mutational Analysis
Actionable Targets in Pancreatic Cancer Detected by Imunohistochemistry (IHC), Microarray (MA) Fluorescent in situ Hybridization (FISH) and Mutational Analysis
Abstract Brain metastases frequently develop in patients with non-small cell lung cancer (NSCLC) and are a common cause of cancer-related deaths, yet our understanding of… […]
Real-world evidence provides clinical insights into tissue-agnostic therapeutic approvals
Abstract The US Food and Drug Administration approves tissue-agnostic therapies to target tumor biomarkers regardless of tumor type. In light of the growing number of… […]